Chesterfield Special Cylinders reports H1 loss but eyes H2 profitability with robust £18m order book driving record Hydrogen & Integrity Management revenues. (149 characters)
This article covers information on Chesterfield Special Cylinders Hdgs.
LON:CSCChesterfield Special Cylinders Holdings (CSC), formerly known as Pressure Technologies, has just dropped its interim results for the 26 weeks ending 29 March 2025. The headline grabber? A loss. But as any seasoned investor knows, the devil – and often the opportunity – is in the detail. This feels less like a company floundering and more like one strategically navigating a transition, heavily weighted towards a potentially bumper second half.
CEO Chris Walters doesn’t shy away from the dip, attributing it squarely to “the phasing of contracts weighted heavily to the second half of the year.” Essentially, the big-ticket work is scheduled for later in their financial year. The proof? A stellar order intake of £14.2 million during the period, propelling the order book to £18.0 million – significantly higher than the £14.9 million seen a year prior.
Arguably the most transformative event was October 2024’s completion of the Precision Machined Components (PMC) division sale. This wasn’t just tidying up the shop; it was a strategic reset:
This move sharpens CSC’s focus squarely on its core strengths: Special Cylinders for Defence and Hydrogen, and Integrity Management services.
Management isn’t whispering hopes; it’s projecting with conviction:
CEO Chris Walters summarises: “Record full-year revenue performance is anticipated for hydrogen and Integrity Management services, while strong order intake and order book coverage underpin second-half revenue expectations and a return to full-year Adjusted EBITDA profitability.”
CSC’s H1 results show a company in transition, bearing the short-term cost of contract phasing and strategic disposals. The reported loss is real, but context is king. The sale of PMC has fundamentally strengthened the balance sheet, eliminating debt and providing ample cash. Crucially, the £18 million order book isn’t just a number; it’s the tangible pipeline driving the confident outlook for a profitable H2 and record performances in key growth sectors (Hydrogen & Integrity Management).
The delayed HAR1 hydrogen contract is a watchpoint, but progress in overseas defence and the strategically vital bp Aberdeen win are significant positives. For investors, the story hinges on the delivery of that H2-weighted order book. If CSC executes as planned, this interim loss could well be the prelude to a much brighter full-year picture and progress towards those ambitious 2028 targets.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
52 viewsLikes
No ratings yet
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.